BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the ...
Modern forensic anthropology, archaeology and historical research are allowing early American colonists to tell their stories in a new exhibition, “Written in Bone: Forensic Files of the 17th-Century ...
Bone Biologics, a developer of advanced orthobiologic products, has filed a U.S. patent application for its NELL-1 protein technology. This novel approach aims to improve the success rates of spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results